BlueAllele “plausibly alleged” that some of Intellia’s uses of technology were not reasonably related to FDA approval | Biotech claimed competitor received over $100m from Regeneron for using ...
Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with verdict l Federal circuit overturned ban on EOFlow’s product in June.